Skip to main content
. 2022 Jun 27;12(2):1588–1601. doi: 10.1002/cam4.4969

FIGURE 2.

FIGURE 2

The promoting effect of PCK2 on cell proliferation in ER+ breast cancer. (A) The daily cell count of MCF‐7 (upper) and T47D (lower) with and without PCK2 knockdown. (B) The daily cell count of MCF‐7 (upper) and T47D (lower) with and without PCK2 overexpression. pEZ‐LV157 is the vector control.